MyOCArDIAl vIABIlITy AnD ITS PrEvAlEnCE AnD ClInICAl SIgnIFICAnCE
The term "viable" on the present review refers to the myocardial regiont hat has compromised function but is alive and has potential to recover function after revascularization. Although terminology and pathophysiology behind this phenomenon varies, the detailed analysisi sb eyond the scope of this review. However,itisimportant to realise that various imaging techniques measured ifferent characteristics of viability such as nuclear function,metabolicfunction, contractile function, membrane function, etc.Itisalso important to notice that although individual myocytes may only be viable or non-viable, the macroscopic myocardium has ac ontinuum from fully viable, through areas of partial infarction, to areas of scar with no remainingmyocytes.
In patientsw ith chronic left ventricular dysfunction, the frequencyofsegmental recovery of function after revascularisation as well as the proportion of patients showing functional recovery has been estimated to be 50-60% even in patients with baseline ejection fraction below 40% (5, 6). However,the true prevalence of recoverabled ysfunction is likely even higher because the revascularization is seldom complete and because recovery may take up to one year to recover function (7, 8) .
Althought he phenomenon is quite common, the presence of viability is not always the main justification for revascularization and not all patients need imaging to detect it. The main value of noninvasive imaging of viability is in the mores everely and chronically disabled patient, in whom the outcome withoutintervention is poor but the risk of revascularisation is high (9). The short and long-term outcome is better when the need for revascularisation is guided by preoperative assessment of viability (10). Even in patients being considered for cardiac transplantation, viability assessment can alter the initial choice of treatment in majority of the patients (11).
It is important to keep in mind that the studies have not always included patients with severed ysfunction whereviability testing is the most relevant. InTrODUCTIOn left ventricular function is an important determinant of prognosis and parameters that reflect function and exercise capacity can be used to help predict outcome in patients with heart failure( 1, 2). Coronary heart disease is the most common cause of heart failurein Europe (3). Althoughpharmacologic therapy has improved the prognosis of heart failureh as remained poor.
Althoughi th as been shown that the mortality of patientsw ith left ventricular dysfunction was reduced after revascularisation (4), the peri-operative mortality in patients with left ventricular dysfunction is relatively high and it is important to revascularise only patients who will obtain overall benefit. In patients withouta ngina when symptoms of left ventriculard ysfunction dominate the revascularization decision is difficult because it is less easy to distinguish between irreversible left ventricular dysfunction and dysfunction that might improve after procedure.
recent clinical research has developedi ncreasing knowledge of imaging techniques that can detect and assessm yocardial viability.S eparately or together theset echniques can nowd istinguishi rreversible myocardial infarction from reversible dysfunction with varying degrees of accuracy.The imaging techniques include nuclear imaging, echocardiography, magnetic resonance imagingand multislice-CT.
The aim of this paper is to review current knowledge on the imaging techniques in the assessment of myocardial viability.E ach method has its strengths and weaknesses but in most clinics limited access or expertise do not allow selection of the technique only based on its performance. Furthermore, it is not always clear whether the dominant symptomi sa ngina or heart failure. viability testing is of course more relevant in patients with heart failurebut without limiting angina because the main indication for revascularisation would be to improve left ventricular function rather than to abolish symptoms or ischemia.F inally,i ts hould be kept in mind that although large majorityofthe studies have assessed the accuracy of the imaging technique against the recovery of regional function, clinically morei mportant parameters areg lobal lv function, exercise capacity,q uality of life and long term survival and these areless often assessed (12) .
IMAgIng TECHnIqUES In THE ASSESSMEnT OF vIABIlITy
POSITrOn EMISSIOn TOMOgrAPHy Positron emission tomography(PET) enables quantification myocardial perfusion, glucose utilisation, fatty acid uptake and oxidation, oxygen consumption, contractile function, and presynaptica nd postsynapticn euronal activity. The most common approach in viability imaging with PET is comparing myocardial metabolism and perfusion using FDg and ammonia or other perfusion tracers (13, 14) . normal and stunned myocardium has normal uptake of both FDga nd ammonia, hibernating myocardium has reduced uptakeo fa mmonia with normal or increased uptake of FDg, and infarcted myocardium has concordantly reduced uptakeofboth tracers with the severity of reduction depending upon thedegree of infarction (13) ( Fig. 1 ). In addition, FDgPET imaging is commonly performed as ECg-gated that allow also assessment of local and global lv function.
SInglE PHOTOn EMISSIOn COMPUTED TOMOgrAPHy
Single photon emission tomography (SPECT) has been used extensively for identifying myocardial viability.Several different tracers have been used such as 201-Thallium (Thallium), Tc -99m-2-methoxyisobutylisonitrile (MIBI) and Tc -99m-tetrofosmin. Each of these tracers has their own advantages and disadvantages and each of them require specific imaging protocol and interpretation for viability imaging.
The thallium stress induced perfusion abnormalities alone aren ot predictive of functional recovery, and most recent studies have concentrated on the resting images. The most widely used criterion is simply the extentofregional thallium uptake at rest. redistribution following resting injection has been also reported as am arker of viability.T he most accurate threshold for defining clinically significant viability appears to be between 55 and 60% (15) (16) (17) .
Technetium-labelledtracers have advantages such as ashorter half-life withlowerradiation exposureto the patient and better image quality.H owever,t he uptake may depend moreonperfusion and viability may be underestimated in areas with reduced perfusion at rest. In regions with reduced tracer uptake the tracer uptake has been improved by nitrates (18) and ECg-gating is routinely performed anditispossible to assess myocardial thickening as well as motion. Altogether,S PECT imaging using technetium labelled tracers is likely to perform similarly to thallium in the assessment of viability.
Until recently,P ET imaging has not been widely available. Thus, FDg imaging for myocardial viability has been combined with single photon perfusion tracerss uch as thallium, MIBI and tetrofosmin and this hybrid approach has proved successful. It is also now possible to image FDgu sing ac onventional gamma camera and overallclinical results aresimilar to using conventional PET imagingw ith ammonia andFDg (19) .
ECHOCArDIOgrAPHy
Myocardial infarction, particularly transmural infarction, leads to thinned and akinetic segments at rest. However,i ft he function of an akinetic segment improves with stress this implies the presence of viable myocardium (20) . Echocardiography allows visualising the left ventricular wall thickness and motion. Depending on the transmural extension, infarctsmay becomea kinetic and thinned (14) . low doseso fd obutamine (5 μg/kg/min) aren ormally sufficient to provoke improvement in function in viable segments and if thereisalso inducible ischemia then abiphasic response is seen with initial improvement in function and deterioration at higher doses (Fig. 2) . The extent of myocardialv iability determined in this way predicts outcomeafter revascularisation. limitations arethat the assessment of regional myocardial function is subjective and assesses mainly systolic function. 
MAgnETIC rESOnAnCE IMAgIng
Magnetic resonance imaging(MrI) has an established role in cardiovascular imaging, providing information on anatomy, function and blood flow.T wo dif ferent approaches to the assessment of patients with chronic ischemic left ventricular dysfunction have been used.One is to assess myocardial morphology, function and contractile reserve at rest and during pharmacological stress correspondingly to echocardiography with cine MrI. The other approach is to depict myocardial infarction with contrast agent and late enhancement imaging.
In cine Mr imaging old infarction with end diastolic myocardial thickness of less than 5.5mm has been used as the threshold for clinically significant myocardial viability (21) . Thicker segmentsm ay be viable or they may consist of subendocardial infarction and viable subepicardial layer.
left ventricular contractile reserve can be evaluated with low-dosed obutaminec ine MrIc orrespondingly to method with echocardiography (22) (23) (24) (25) (26) . The strengthofMrI is the accuracy of measurement of global and regional functionb ut is more time-consuming than echocardiography.
late enhancement MrIimaging has been found to be the mosta ccurate technique in the assessment of scar (27) .T he infarctionw ith al arger extracellular space than normalm yocardium appears bright on late enhancement images 6-35 minutes after injection of ac onventionalM rc ontrast agent (28) (Fig. 3) . It has been demonstrated that functional recovery after revascularisation of dysfunctional myocardium is less likely to occur with increasing transmural extent of hyperenhancement.
MUlTISlICE CT
Multislice CT has recently developed rapidly and non-invasivecoronaryangiography canbeperformed with good imageq uality in mosto ft he patients. However,less data is available about the use of CT in the assessment of viability.T he feasible techniques aret he analysis of thickness of the myocardium as well as using late enhancement technique similarly than with MrI ( 29) . The low dose dobutamine approach has not been used likely due to higher radiation dose.
COMPArISOn OF IMAgIng TECHnIqUES
It is evident that several noninvasive techniques can identify viable myocardium, each of them focusing on ad ifferent aspect. The most commonly used approaches areFDg PET,thallium/technetium SPECT and dobutamine echocardiography.These techniques have been used in patients with chronic ischemic left ventricular dysfunction to predict improvement of regional and global function, improvement of heart failuresymptoms and long-term event-free survival. recently also contrast enhanced MrIh as been increasingly used in the assessment of viability but smaller number of clinicalt rials have been published.
rEgIOnAl lEFT vEnTrICUlAr FUnCTIOn
In ar ecent meta-analysis the studies of regional left ventricular function in patients with ischemic left ventricular dysfunction undergoing revascularisation werepooled (5). Dobutamineechocardiography had thehighestpositive predictive value with intermediate values for FDg PET,r est-redistribution thallium SPECT and technetium SPECT,a nd reinjection thallium SPECT had the lowest value (P <0.05 vs others). FDg PET,r einjection thallium SPECT and dobutamine echocardiography had the highest negative predictive values with lower values for rest-redistribution thallium SPECT and technetium SPECT.
In can be summarized that then uclear imaging techniques seem to be mores ensitive in the prediction of recovery of function than the techniques that detect contractile reserve (such as dobutamine echocardiography), whereasthe latter techniques aremore specific for recovery of regional function( 5, 12) ( Fig. 4 ). In addition, it was found that when inducible ischemia assessment was included in the detection of viability,s pecificity of nuclear techniques was increased (30) . Of note, some studies may be biasedby using the technique under investigation (for instance echocardiography) as the golden standardfor pre-and postoperative function (12) .
Contractile reserve can also be evaluated by lowdose dobutamine MrI correspondingly to method with echocardiography (22) (23) (24) (25) (26) . The strength of MrI is the accuracy of measurement of global and regional function but is moret ime-consuming than echocardiography.I nad irect comparison between dobutamine MrI, thallium and tetrofosmin SPECT in patients with ischemic left ventricular dysfunction undergoing revascularisation, MrIhad alow sensitivity (50%) but ahigh specificity (81%) whereas the nuclear techniques werem ores ensitive but less specific for predicting recovery of regional function (16) .
recently,late enhancement MrI imaging has been investigated in the assessment of viability.T he strengthofthis technique is that transmurality of scar canbeaccurately assessed (31) . Although this enables also accurate visualization of non-scarred myocardium, the prediction of wall motion recovery is not straightforward. In segmentsw ithout late enhancement 78% will recover and of those having late enhancement >75% only 2% recovers but those segments having 1-75% of late enhancement about 50% will recover (32) . In recent meta-analysis sensitivity was 92% and specificity4 9% in predicting wall motion recovery using late enhancement MrI (33) .
ve ry little data is available on multislice CT in the assessment of viability.I nt he study by Mahnken et al (29) good agreement between cardiac MSCT and good agreement between cardiac MSCT and MrI was demonstrated in 28 patients with reperfused myocardial infarction. late enhancement in MSCT was as reliable as MrIinassessing viability. 
glOBAl lEFT vEnTrICUlAr FUnCTIOn
The studiesinvestigating the prediction of improvement of global function areuncommon although this is likely morei mportant from ap rognostic point of view than prediction of improvement in regional function. In the meta-analysis (5) information on lvEF beforeand after surgery was analysed (Table 1) and positive viability findings in all techniques were associated with an increase in global lv function. The amount of viable but dysfunctional myocardium necessary to lead to an improvement of lvEF after revascularisation has been estimated to be roughly 25% (34) .
SyMPTOMS AnD PrOgnOSIS
Despite most of the published papers arefocusing on regional and global lv function, symptoms and prognosis aret he most important outcomes to consider when assessing patients with left ventricular dysfunction for revascularisation. Only limited number of uncontrolled and observational studies has assessed this directly (35, 36) . However,itseems that relationship between the extento fv iability beforer evascularisation and the improvement in symptoms afterwards exists, and exercise capacity also improves (37) . Beanlands et al (11) showed that viability imaging changed the therapy in 46% of the patients.
The studiesthat have included also prognosis after viability testing have used either FDgPET,thallium SPECT or echocardiography.T hose studies demonstrated that in patients with viablebut dysfunctional myocardium but who are continuing medical therapy have high annual mortality (16%) while those who werer evascularized have clearly lower event rate (3%). In those patients without viable but dysfunctional myocardium event rate was the same independently whether they wererevascularized or not (38) . More prospective and randomised studies are needed to draw definitive conclusions on the prognostic value of viability assessment in candidates for revascularization.
ClInICAl IMPlICATIOnS
In patients with chronic left ventricular dysfunction, cardiac function is commonly improved after revascularization. In mores everely and chronically disabled patients the noninvasive imaging has been shown to be useful in guidingrevascularization decision. It has been shown that imagingcan predict regionaland global wall motion recovery,improvement in symptoms and exercise capacity.I na ddition, the short and long-term outcome is better when the need for revascularisation is based on viability imaging.
Thereare several alternative techniques that can be used for the assessment of myocardial viability.Each method has its strengths and weaknesses but in most clinics limited access or expertise determinethe selection of the technique.
In recent consensus paper (12) several conclusions weres tated. The assessment of myocardial hibernation is most relevant in the patients with aprincipal symptom of dyspnoea rather than angina. Myocardial perfusion scintigraphyand stress echocardiography have similar capabilities for the detection of viable and hibernating myocardium. Magnetic resonance imaging was considered asecondary imaging technique until morep rognostic information is obtainedbut if it is readily available it is agood alternative to echocardiography for the assessment of rest and stress left ventricular function. Positron emission tomography cannormally be reserved for when clinical suspicion of viability or hibernation remains after other imaging techniques have proved negative. However,ifpositron emission tomography is readily available it is agood alternative. rEFErEnCES 0 1. Cohn Jn, Johnson gr, Shabeti re ta l: Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993;87:vI-5-vI-16 Circulation 1993;87:vI-5-vI-16 0 2. Fallavollita JA, Jacob S, young rF et al: regional alterations in regional alterations in Sr Ca(2+)-ATPase, phospholamban, and HSP-70 expression in chronic hibernating myocardium. Am JP hysiol 1999;277: H1418-28 0 3. 
